Connection
David Simpson to Creatine Kinase
This is a "connection" page, showing publications David Simpson has written about Creatine Kinase.
|
|
Connection Strength |
|
 |
|
 |
|
0.114 |
|
|
|
-
Simpson DM, Katzenstein DA, Hughes MD, Hammer SM, Williamson DL, Jiang Q, Pi JT. Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175/801 Study Team. AIDS. 1998 Dec 24; 12(18):2425-32.
Score: 0.040
-
Simpson DM, Slasor P, Dafni U, Berger J, Fischl MA, Hall C. Analysis of myopathy in a placebo-controlled zidovudine trial. Muscle Nerve. 1997 Mar; 20(3):382-5.
Score: 0.035
-
Morgello S, Wolfe D, Godfrey E, Feinstein R, Tagliati M, Simpson DM. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy. Acta Neuropathol. 1995; 90(4):366-74.
Score: 0.030
-
Scelsa SN, Simpson DM, McQuistion HL, Fineman A, Ault K, Reichler B. Clozapine-induced myotoxicity in patients with chronic psychotic disorders. Neurology. 1996 Dec; 47(6):1518-23.
Score: 0.009